URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Aram Hezel

Concepts (204)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Pancreatic Neoplasms
13
2006
82
3.880
Why?
Biliary Tract Neoplasms
3
2008
6
2.110
Why?
Carcinoma, Pancreatic Ductal
7
2006
14
1.880
Why?
Cholangiocarcinoma
4
2008
13
1.820
Why?
Liver Neoplasms
4
2009
151
1.790
Why?
Protein-Serine-Threonine Kinases
6
2002
276
1.500
Why?
Pancreas
3
2006
127
1.220
Why?
Disease Models, Animal
7
2006
956
1.180
Why?
Gallbladder Neoplasms
3
2010
8
1.140
Why?
Phosphatidylinositol 3-Kinases
5
2007
157
1.070
Why?
Proto-Oncogene Proteins p21(ras)
3
2011
16
1.070
Why?
Tumor Suppressor Protein p53
5
2001
138
1.020
Why?
Carcinoma, Hepatocellular
2
2009
68
0.930
Why?
Signal Transduction
9
2005
1567
0.830
Why?
Integrins
1
2012
48
0.820
Why?
Antigens, Neoplasm
1
2012
106
0.780
Why?
Molecular Targeted Therapy
1
2011
17
0.750
Why?
Radiosurgery
1
2011
74
0.740
Why?
Colorectal Neoplasms
2
2007
137
0.690
Why?
Transforming Growth Factor beta
2
2006
412
0.690
Why?
Carcinoma
1
2011
191
0.660
Why?
Cellular Structures
1
2008
3
0.660
Why?
Liver Transplantation
1
2011
237
0.650
Why?
Genomic Instability
2
2005
20
0.650
Why?
Proto-Oncogene Proteins c-pim-1
1
2008
1
0.650
Why?
Telomere
2
2005
27
0.650
Why?
Genes, ras
6
2001
34
0.640
Why?
Neoplastic Syndromes, Hereditary
1
2008
1
0.620
Why?
Cystadenoma, Serous
1
2008
2
0.620
Why?
Disease Progression
7
2006
521
0.610
Why?
Proto-Oncogene Proteins
4
2007
289
0.600
Why?
Adenocarcinoma
5
2006
439
0.570
Why?
ras Proteins
3
2010
35
0.560
Why?
Animals
22
1999
16093
0.560
Why?
Mice
17
1999
6111
0.560
Why?
Tumor Markers, Biological
1
2008
229
0.540
Why?
Genes, Tumor Suppressor
4
2002
49
0.490
Why?
Antineoplastic Agents
4
2007
619
0.470
Why?
Humans
23
2005
36274
0.470
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
429
0.460
Why?
Mutation
5
2008
1216
0.440
Why?
Protein Kinases
3
2007
113
0.430
Why?
Neoplasms
1
2008
739
0.400
Why?
Bile Ducts, Intrahepatic
2
2011
8
0.390
Why?
Bile Duct Neoplasms
2
2011
14
0.390
Why?
TOR Serine-Threonine Kinases
3
2007
29
0.380
Why?
Deoxycytidine
3
2008
28
0.380
Why?
Indoles
2
2009
101
0.340
Why?
Lung Neoplasms
3
2006
439
0.340
Why?
Aging
1
2005
707
0.320
Why?
Cell Polarity
2
2008
30
0.320
Why?
Peutz-Jeghers Syndrome
2
2002
3
0.270
Why?
Cell Transformation, Neoplastic
3
2002
137
0.270
Why?
Treatment Outcome
4
2007
2615
0.250
Why?
Mice, Mutant Strains
5
1999
123
0.250
Why?
Cyclin-Dependent Kinase Inhibitor p16
4
2001
14
0.240
Why?
Middle Aged
7
2008
9837
0.230
Why?
Gene Deletion
4
2002
190
0.230
Why?
Aged
5
2008
7269
0.220
Why?
Isocitrate Dehydrogenase
1
2011
23
0.200
Why?
Waiting Lists
1
2011
12
0.200
Why?
Tumor Burden
1
2011
22
0.200
Why?
Genetic Engineering
1
2012
22
0.200
Why?
Dose Fractionation
1
2011
60
0.200
Why?
Necrosis
1
2011
103
0.200
Why?
Tumor Suppressor Protein p14ARF
3
2001
6
0.200
Why?
beta Karyopherins
1
2011
14
0.200
Why?
PTEN Phosphohydrolase
1
2011
16
0.190
Why?
Organ Size
1
2011
192
0.190
Why?
Validation Studies as Topic
1
2011
3
0.190
Why?
Tubulin
1
2011
55
0.190
Why?
Mice, Transgenic
3
2008
749
0.190
Why?
Immunohistochemistry
2
2006
1064
0.190
Why?
Cisplatin
1
2011
95
0.180
Why?
Female
8
2007
19838
0.180
Why?
DNA Mutational Analysis
1
2011
189
0.180
Why?
Proto-Oncogene Proteins c-akt
2
2007
128
0.180
Why?
Drug Therapy, Combination
1
2011
382
0.170
Why?
Male
7
2008
19675
0.170
Why?
NF-kappa B
2
2007
432
0.170
Why?
Aged, 80 and over
3
2009
2529
0.170
Why?
MAP Kinase Signaling System
1
2010
89
0.170
Why?
Pyrroles
1
2009
21
0.170
Why?
Amyloid Precursor Protein Secretases
1
2009
13
0.170
Why?
p21-Activated Kinases
1
2008
3
0.170
Why?
Pancreatic Ducts
1
2008
4
0.170
Why?
Mice, Knockout
3
2002
895
0.170
Why?
rho GTP-Binding Proteins
1
2008
22
0.160
Why?
Sirolimus
1
2008
31
0.160
Why?
Liver
2
1999
877
0.160
Why?
Metaplasia
1
2008
18
0.160
Why?
Receptors, Notch
1
2009
59
0.160
Why?
Tight Junctions
1
2008
16
0.150
Why?
Neoplasms, Squamous Cell
1
2008
10
0.150
Why?
Fluorouracil
1
2008
78
0.150
Why?
Islets of Langerhans
1
2008
87
0.150
Why?
Carcinogens
1
2008
63
0.150
Why?
Antibodies, Monoclonal
1
2011
711
0.150
Why?
Cytoskeleton
1
2008
74
0.150
Why?
Proto-Oncogene Proteins c-met
1
2007
16
0.150
Why?
Cytokines
1
2011
565
0.150
Why?
Receptors, Growth Factor
1
2007
30
0.150
Why?
Cohort Studies
1
2011
969
0.150
Why?
Energy Metabolism
1
2008
137
0.140
Why?
Magnesium Compounds
1
2007
5
0.140
Why?
Prednisolone
1
2007
24
0.140
Why?
src-Family Kinases
1
2007
60
0.140
Why?
Smad4 Protein
1
2006
16
0.140
Why?
Calcium Oxalate
1
2007
32
0.140
Why?
Protein Processing, Post-Translational
1
2008
138
0.140
Why?
Cats
1
2007
215
0.140
Why?
Receptor, Epidermal Growth Factor
1
2007
93
0.140
Why?
Protein Kinase Inhibitors
1
2007
92
0.140
Why?
Models, Biological
2
2007
1008
0.140
Why?
Biological Markers
1
2009
560
0.130
Why?
Phosphates
1
2007
147
0.130
Why?
Adult
5
2008
11351
0.130
Why?
Genes, p53
1
2006
51
0.130
Why?
Retinoblastoma Protein
2
2001
35
0.130
Why?
Enzyme Activation
1
2008
554
0.130
Why?
Anti-Inflammatory Agents
1
2007
110
0.130
Why?
Cell Line, Tumor
4
2006
575
0.130
Why?
Epithelial Cells
1
2008
327
0.130
Why?
Randomized Controlled Trials as Topic
1
2008
411
0.130
Why?
Retrospective Studies
1
2011
2267
0.130
Why?
Prognosis
1
2008
1083
0.130
Why?
Phosphorylation
1
2008
774
0.120
Why?
Skin Neoplasms
1
2008
229
0.120
Why?
Cell Proliferation
1
2008
515
0.120
Why?
Administration, Oral
3
2007
308
0.120
Why?
Pneumonia
1
2006
196
0.110
Why?
Intestinal Polyps
1
2002
15
0.110
Why?
Drug Resistance, Neoplasm
2
2008
56
0.090
Why?
Melanoma
1
2001
134
0.080
Why?
Neoplasm Metastasis
2
2008
228
0.080
Why?
Carrier Proteins
1
2002
426
0.080
Why?
Mutagenesis
1
1999
130
0.080
Why?
DNA Repair
1
1999
172
0.070
Why?
Phenotype
2
2006
763
0.060
Why?
DNA-Binding Proteins
1
1999
685
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2001
256
0.050
Why?
Demography
1
2011
101
0.050
Why?
Animals, Genetically Modified
1
2011
54
0.050
Why?
Genotype
1
2011
490
0.040
Why?
Chemokine CXCL12
1
2009
34
0.040
Why?
Cyclic S-Oxides
1
2009
1
0.040
Why?
Thiadiazoles
1
2009
12
0.040
Why?
Oncogene Protein v-akt
1
2008
5
0.040
Why?
Survival Analysis
1
2011
606
0.040
Why?
Cell Line, Transformed
1
2008
63
0.040
Why?
Neoplasm Staging
1
2010
338
0.040
Why?
Genomics
1
2008
46
0.040
Why?
Combined Modality Therapy
1
2010
486
0.040
Why?
Mice, Nude
1
2008
183
0.040
Why?
Neoplasm Invasiveness
1
2008
155
0.040
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
36
0.040
Why?
Transcription, Genetic
1
2012
812
0.040
Why?
Survival Rate
1
2010
618
0.040
Why?
Epidermis
1
2008
82
0.040
Why?
Cat Diseases
1
2007
2
0.040
Why?
Urinalysis
1
2007
18
0.040
Why?
Young Adult
1
2011
1059
0.040
Why?
Stromal Cells
1
2007
66
0.040
Why?
Urinary Calculi
1
2007
32
0.040
Why?
Cross-Over Studies
1
2007
128
0.030
Why?
Interleukin-6
1
2009
339
0.030
Why?
Alleles
1
2006
205
0.030
Why?
Homozygote
1
2006
97
0.030
Why?
Cell Movement
1
2008
361
0.030
Why?
Cyclooxygenase 2
1
2007
226
0.030
Why?
Mice, Inbred C57BL
1
2011
1675
0.030
Why?
Macrophages, Alveolar
1
2006
118
0.030
Why?
Stem Cells
1
2009
361
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2006
303
0.030
Why?
DNA Primers
1
2006
403
0.030
Why?
Cell Line
1
2009
1585
0.030
Why?
Time Factors
1
2011
3182
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
542
0.030
Why?
Magnetic Resonance Imaging
1
2009
991
0.030
Why?
Child
1
2011
4155
0.030
Why?
Culture Media, Conditioned
1
2002
62
0.030
Why?
Gene Targeting
1
2002
68
0.030
Why?
Adolescent
1
2011
4766
0.030
Why?
Cell Aging
1
2002
57
0.030
Why?
Base Sequence
1
2006
1683
0.020
Why?
cdc25 Phosphatases
1
2001
1
0.020
Why?
Cyclin D1
1
2001
32
0.020
Why?
S Phase
1
2001
47
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2001
47
0.020
Why?
G1 Phase
1
2001
52
0.020
Why?
Gene Silencing
1
2001
41
0.020
Why?
Cell Differentiation
1
2006
1093
0.020
Why?
Cyclins
1
2001
52
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2001
70
0.020
Why?
In Situ Hybridization
1
2001
323
0.020
Why?
Xeroderma Pigmentosum Group A Protein
1
1999
2
0.020
Why?
Chimera
1
1999
35
0.020
Why?
Fibroblasts
1
2002
534
0.020
Why?
Lac Operon
1
1999
59
0.020
Why?
Genes, Reporter
1
1999
208
0.020
Why?
Proteins
1
2001
468
0.020
Why?
Age Factors
1
1999
1128
0.020
Why?
RNA, Messenger
1
2002
1863
0.020
Why?
Brain
1
1999
1214
0.010
Why?

Visualizations


Hezel's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department